Trials / Completed
CompletedNCT06614816
Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Children Aged 1-12 Years
Phase III Clinical Trial of Lyophilized Live Attenuated Varicella Vaccine for Children Aged 1-12 Years
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,200 (actual)
- Sponsor
- Southeast University, China · Academic / Other
- Sex
- All
- Age
- 1 Year – 12 Years
- Healthy volunteers
- Accepted
Summary
Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Children Aged 1-12 Years: A Phase III, Randomized, Double-Blind, Active-Controlled Study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Oka strain varicella attenuated live vaccine | lyophilized powder, subcutaneous injection |
Timeline
- Start date
- 2019-02-10
- Primary completion
- 2021-07-15
- Completion
- 2022-06-20
- First posted
- 2024-09-26
- Last updated
- 2024-09-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06614816. Inclusion in this directory is not an endorsement.